Transactivating DNA-binding protein-43 (TDP-43) inclusions and the accumulation of phosphorylated and ubiquitinated tau proteins (p-tau) have been identified in postmortem brain specimens from patients with chronic traumatic encephalopathy (CTE). To examine whether these proteins contribute to the development of CTE, we utilized an in vitro trauma system known to reproduce many of the findings observed in humans and experimental animals with traumatic brain injury. Accordingly, we examined the role of TDP-43 and Tau in an in vitro model of trauma, and determined whether these proteins contribute to the defective neuronal integrity associated with CNS trauma. Single or multiple episodes of trauma to cultured neurons resulted in a time-dependent increase in cytosolic levels of phosphorylated TDP-43 (p-TDP-43). Trauma to cultured neurons also caused an increase in levels of casein kinase 1 epsilon (CK1e), and ubiquitinated p-TDP-43, along with a decrease in importin-b (all factors known to mediate the "TDP-43 proteinopathy"). Defective neuronal integrity, as evidenced by a reduction in levels of the NR1 subunit of the NMDA receptor, and in PSD95, along with increased levels of phosphorylated tau were also observed. Additionally, increased levels of intra-and extracellular thrombospondin-1 (TSP-1) (a factor known to regulate neuronal integrity) were observed in cultured astrocytes at early stages of trauma, while at later stages decreased levels were identified. The addition of recombinant TSP-1, conditioned media from cultured astrocytes at early stages of trauma, or the CK1e inhibitor PF4800567 hydrochloride to traumatized cultured neurons reduced levels of p-TDP-43, and reversed the traumainduced decline in NR1 subunit of the NMDA receptor and PSD95 levels. These findings suggest that a trauma-induced increase in TDP-43 phosphorylation contributes to defective neuronal integrity, and that increasing TSP-1 levels may represent a useful therapeutic approach for the prevention of the neuronal TDP-43 proteinopathy associated with CTE. Keywords: astrocytes, chronic traumatic encephalopathy, neurons, p-tau, TDP-43 proteinopathy, thrombospondin-1. 
Chronic traumatic encephalopathy (CTE) is a neurological disorder generally occurring after single or multiple episodes of head trauma (Miller 1966; McKee et al. 2009 McKee et al. , 2010 McKee et al. , 2013 Omalu et al. 2011; Stein et al. 2014) . While CTE shares many features of other neurodegenerative disorders, including Alzheimer disease (AD), progressive supranuclear palsy, post-encephalitic Parkinsonism, and the amyotrophic lateral sclerosis/Parkinson's-dementia complex of Guam, CTE is a neuropathologically distinct progressive tauopathy (McKee et al. 2009) . CTE is frequently diagnosed in boxers, as well as in other athletes who have experienced multiple brain concussions (De Michelis 1953; Brandenburg and Hallervorden 1954; Saulle and Greenwald 2012; Lakis et al. 2013; Ban et al. 2016) . CTE is also an important complication in military veterans (Lew 2005; Taber et al. 2006; Omalu et al. 2011; Goldstein et al. 2012; Shively and Perl 2012; Rosenfeld et al. 2013) . CTE is clinically characterized by progressive neurobehavioral and cognitive deficits, confusion, alterations in sleep patterns, depression and suicidal tendencies (McKee et al. 2013; Stern et al. 2013; Stein et al. 2014 ). Yet, little is currently known about the molecular and cellular events underlying CTE pathogenesis.
Recent studies have documented the presence of the transactivating DNA-binding protein-43 (TDP-43) neuronal inclusions in the early phase of CTE, along with the accumulation of phosphorylated tau (p-tau) in post-mortem brains from patients with CTE (McKee et al. 2010) . While ptau accumulation was observed only in the late stages of CTE, the TDP-43 proteinopathy has been observed in both early and late stages (Ojo et al. 2016) . TDP-43 is a transcriptional regulator (MW 43 kDa) that normally resides in the nucleus and is a component of ribonuclear protein complexes consisting of mRNAs, noncoding RNAs and RNA-binding proteins (Sephton et al. 2011) . TDP-43 is also capable of binding to DNA, and such binding has been postulated to play an important role in the regulation of gene expression (Sephton et al. 2011) . However, hyperphosphorylated/ubiquitinated and aggregated forms of TDP-43 (the TDP-43 proteinopathy) in brains of patients with frontotemporal lobe dementia, or with amyotrophic lateral sclerosis, have been shown to contribute to neuronal injury Arai et al. 2010) .
While TDP-43 inclusions have been reported in CTE (McKee et al. 2010) , precisely how this event is regulated and contributes to the pathogenesis of CTE remains poorly understood. We therefore examined whether the TDP-43 proteinopathy occurs in an in vitro model of single or multiple episodes of mild chronic traumatic injury, and whether this proteinopathy contributes to the progression of neuronal injury. Additionally, since astrocytes are known to be critically involved in the maintenance of neuronal integrity (Newman 2003; Ehlers 2005; Slezak et al. 2006; Lo et al. 2011; Jayakumar et al. 2014a) , and since astrocytic dysfunction is known to negatively impact neuronal integrity in other neurological conditions (Norenberg 1998; Ullian et al. 2004; Jayakumar et al. 2014a) , we examined whether trauma-induced dysfunctional astrocytes also contribute to the development of TDP-43 proteinopathy. A preliminary account of these findings was presented at the American Society for Neurochemistry, March 2016.
Materials and methods

Astrocyte cultures
Primary cultures of cortical astrocytes were prepared from brains of 1-to 2-day-old rat (albino Fisher 344) pups by the method of Ducis et al. (1990) and Jayakumar et al. (2014a) . Briefly, a cerebral cortical cell suspension derived from individual animals (both sexes) were pooled and then seeded onto 35 mm culture dishes and 14 days later these cultures were treated with 0.5 mM dibutyryl cAMP (Sigma, St. Louis, MO, USA) to enhance cellular differentiation (Juurlink and Hertz 1985) . Cultures consisted of at least 95% astrocytes as determined by glial fibrillary acidic protein immunohistochemistry. All cultures used were 21-23 days old.
Neuronal cultures
Cortical neuronal cultures were prepared by a modification of the method described by Schousboe et al. 1989 . Briefly, cortices were removed from 16-to 18-day-old rat (albino Fisher 344) fetuses, pooled, and placed in Dulbecco's modified Eagle's medium-high glucose (30 mM) solution-containing 25 mM KCl and 10% horse serum. The tissue was minced and mechanically dissociated with a pipette. Approximately 1-2 9 10 6 cells per mL were seeded onto poly-D-lysine coated 35 mm culture dishes. To prevent the proliferation of astrocytes, cytosine arabinoside (10 lM) was added to the culture medium 48 h after seeding. These cultures consist of at least 90% neurons as determined by immunohistochemical staining for neurofilament protein; the remaining cells were predominantly astrocytes. Experiments were performed on cultures that were 7-8 days old.
Fluid percussion injury model of in vitro trauma
The fluid percussion instrument employed was initially described by Sullivan et al. 1976 ; and subsequently modified for cell culture by Shepard et al. (1991) and Panickar et al. (2002) , which reliably produces consistent degrees of traumatic cell injury (Jayakumar et al. 2008a (Jayakumar et al. , 2011 (Jayakumar et al. , 2014b (Jayakumar et al. , 2016 . Briefly, astrocyte and neuronal cultures grown in individual 35 mm culture dishes were placed in the injury chamber coupled to the fluid percussion device, and were then exposed to three atms pressure by briefly striking the piston (two strikes, each 25-ms duration). Sham controls were treated exactly as the traumatized cells, except that fluid percussion was omitted.
Immunoblotting
Following trauma, the culture media was collected, and cells lysed with 125 mM Tris-HCl 6.8; 4% sodium dodecyl sulfate (SDS), and a protease inhibitor mixture (Roche Products, Indianapolis, IN, USA). The collected media was concentrated for extracellular thrombospondin-1 (TSP-1) measurement, using an Amicon Ultra 4 centrifugal filter device having a 10 000 molecular weight cutoff (Millipore, Billerica, MA, USA), according to the manufacturer's instructions. Protein concentrations were measured by the bicinchoninic acid method following the manufacturer instructions (Pierce TM BCA Protein Assay Kit #23225, Life Technologies Corporation, Grand Island, NY, USA). Equal amounts of protein were subjected to SDS-polyacrylamide gel electrophoresis using 4-20% gels (Tris-HCl), and then electrophoretically transferred to a polyvinylidene difluoride membrane as described previously (Jayakumar et al. 2014a) . Blots were blocked with 5% bovine serum albumin in Tris-buffered saline-T (TBS; 20 mM Tris-HCl, 150 mM NaCl, pH 7.4, and 0.05% Tween 20) for 2 h at room temperature (RT) (24°C) and then incubated with respective primary antibodies at 4°C overnight. Membranes were washed with Trisbuffered saline-Tween 20 and incubated with horseradish peroxidase-conjugated secondary antibodies for 2 h at 24°C. After washing, membranes were visualized, using enhanced chemiluminescence reagents (ECL-plus; Amersham Biosciences, Piscataway, NJ, USA). Primary antibodies used in this study included: (i) anti-TSP-1 (Ab-3; mouse monoclonal antibody A6.1, cat# BA24; Millipore); (ii) anti-TDP-43 Phospho (Ser409/410) Antibody cat# 829901; BioLegend (San Diego, CA, USA) (previously Covance catalog# SIG-39852); (iii) postsynaptic density protein 95 (PSD95), EMD Millipore (Billerica, MA, USA) (cat# 3540); (iv) Phospho-PHF-tau pSer202+Thr205 Antibody (AT8), Life Technologies Corporation (cat# MN1020); (v) Ubiquitin antibody (FL-76), sc-9133; Santa Cruz Biotechnology, Inc. (Dallas, TX, USA). Primary antibodies for CK1e (Cat#13517-1-AP) were purchased from Proteintech Group, Inc. Chicago, IL, USA; anti-a-and b-tubulin antibodies were obtained from Oncogene (San Diego, CA, USA) and Sigma-Aldrich (St. Louis, MO, USA). All primary antibodies were used at 1 : 1000 dilutions.
Anti-rabbit and anti-mouse horseradish peroxidase-conjugated secondary antibodies (Vector Laboratories, Burlingame, CA, USA) were used at 1 : 1000. The optical density of the bands was measured with the Chemi-Imager digital imaging system (Alpha Innotech, San Leandro, CA, USA), and the results quantified with the Sigma Scan Pro program (St. Louis, MO, USA) as a proportion of the signal of a house-keeping protein band (a-tubulin, for astrocytes and b-tubulin for neurons). Controls, which included omission of the primary antibodies, did not display a band.
The cytosolic and nuclear extracts were prepared as previously described (Sinke et al. 2008) . In brief, control and traumatized neurons were washed twice with phosphate-buffered saline (PBS); the neurons harvested in 1 mL PBS and centrifuged at 1147.06 g for 3 min at 4°C; the cell pellet was resuspended in buffer consisting of 10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 lM dithiothreitol, and a complete protease inhibitor cocktail (Roche, Mannheim, Germany). The cell pellet was then incubated on ice for 20 min to allow the cells to swell and 15 lL of 10% NP-40 was then added, and the sample vortexed for 1 min. Cells were then centrifuged at 1147.06 g for 3 min at 4°C. The supernatant (cytosolic fraction) was collected, and the nuclear pellet was resuspended in 30 lL of buffer consisting of 20 mM HEPES (pH 7.9), 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1 lM dithiothreitol, and protease inhibitors. The pellet was then incubated on ice, vortexed for 15 s every 2 min for up to 15 min and, the nuclear extract centrifuged at 7746.6 g for 5 min at 4°C. The supernatant (nuclear extract) and cytosolic fractions were then loaded on an SDS-PAGE, and western blots (WB) performed as described above. The quality of the nuclear extract was analyzed by propidium iodide staining, which indicated a purity of 95-98% (see Fig. 1d ).
Co-immunoprecipitation
Immunoprecipitation was performed as previously described (Jayakumar et al. 2008b) . Briefly, equal amounts of pre-cleared cell lysates from sham control and traumatized neuronal cultures were incubated with pre-equilibrated protein A/G agarose beads (Millipore), along with p-TDP-43 antibody Phospho (Ser409/410) Antibody cat# 829901; BioLegend (previously Covance catalog# SIG-39852)] at 4°C overnight. Co-precipitates were separated on 10% SDS gels followed by immunoblotting, as described above, with an anti-ubiquitin antibody (FL-76), sc-9133; Santa Cruz Biotechnology, Inc. Similarly, equal volume of cell culture media from sham control and traumatized astrocytes were incubated with pre-equilibrated protein A/G agarose beads (Millipore), along with TSP-1 antibody (Ab-3; mouse monoclonal antibody A6.1, cat# BA24; Millipore) at 4°C overnight. The resulting supernatant (media) were concentrated for extracellular TSP-1 measurement, using an Amicon Ultra 4 centrifugal filter device as previously described (Jayakumar et al. 2014a) . Equal amounts of protein were subjected to SDS-PAGE, using 4-20% gels (Tris-HCl), and then electrophoretically transferred to a polyvinylidene difluoride membrane for TSP-1 detection, as described above.
TSP-1 over-expression in cultured astrocytes
To examine whether the exposure of cultured neurons to conditioned media (CM) from traumatized astrocytes, in which TSP-1 is over-expressed, diminishes or prevents the increase in neuronal TDP-43 phosphorylation, we over-expressed TSP-1 in cultured astrocytes as previously described (Jayakumar et al. 2014a) . Briefly, astrocytes were transfected with TSP-1 cDNA (tagged with the pIRES2-AcGFP1 vector; GENEWIZ Inc, South Plainfield, NJ, USA). Cultures were exposed to 100 ng TSP-1 cDNA for 72 h. The Mirus TransIT-TKO transfection reagent was used to transfect TSP-1 following the manufacturer instructions (Mirus, #MIR 2150) . At the end of transfection, the culture media were replaced with normal media. These cultures were then traumatized and 15 days later, intra-and extracellular levels of TSP-1 were measured by western blots. The CM from traumatized astrocytes (15 days post-trauma) was transferred to neurons and the level of p-TDP-43 was measured 3 days later. The empty vectors, as well as the transfection reagent alone, were used as controls for all experiments.
RNA isolation and RT-qPCR Isolation of mRNA was performed as previously described (Curtis et al., 2010 
Cytotoxicity assay
Lactate dehydrogenase (LDH) activity was measured as described by Wroblewski and LaDue 1955 with modifications (Jayakumar et al. 2004) . Released LDH was calculated as the percentage of LDH in the medium as compared to the total LDH activity (cells plus medium).
RNA interference
For the inhibition of importin-b gene expression, short-interfering RNA (siRNA) specific to importin-b (cat# sc-156145; Santa Cruz Biotechnology) was used. A scrambled siRNA sequence (sc-37007; Santa Cruz Biotechnology) was used as a non-silencing control. Cells were transiently transfected with siRNA, using the 'TransIT- Nuclear p-TDP-43 level decreased at day 1; no change occurred at day 3, while a slight increase was observed at day 5 after trauma. Lamin AC, loading control for nuclear p-TDP-43. (b and c) Quantitation of cytosolic and nuclear p-TDP-43. (d) Propidium iodide staining of cytosolic and nuclear extract. Data were subjected to a two-way analysis of variance followed by Tukey's multiple comparison test, n = 9 for (a-c) and culture media from seven independent experiments were pooled for (d). *p < 0.05 versus sham control. Error bars represent mean AE SEM. C, sham control; T, trauma.
TKO' transfection reagent (cat# MIR 2150; Mirus, Madison, WI, USA) as previously described (Jayakumar et al. 2011) . Transfection times and siRNA concentrations for optimal transfection were tested using different concentrations of siRNA (10, 20, 30 and 40 nM) , and different transfection incubation times (24-96 h) (Jayakumar et al. 2011) . Importin-b silencing was confirmed by RT-qPCR and western blots. Primer pairs include F 5 0 -CCAGTGCCGAGTG-
Cell immunofluorescence PSD95 immunofluorescence was performed as previously described (Jayakumar et al. 2014a) . Briefly, sham control and traumatized cultures were washed with PBS and incubated in ice-cold methanol for 10 min. Following washing with PBS, cultures were blocked with 5% bovine serum albumin for 30 min at 24°C and incubated in anti-PSD95, EMD Millipore (cat# 3540; 1-100 dilution). Immunofluorescent images were acquired with a Zeiss LSM510/ UV Axiovert 200M confocal microscope (Jena, Germany) with a plan apochromat 409 objective lens, and a 29 zoom as described previously (Jayakumar et al. 2014a) . Random collection of images from control and traumatized cells were achieved by systematically capturing each image in a "blinded" manner by moving the microscope stage approximately 4 mm in four different directions. At least 96 fluorescent images were captured per culture plate from nine different cell cultures. Green fluorescent images (PSD95 levels) were quantified, using the Volocity 6.0 High Performance Cellular Imaging Software (PerkinElmer, Santa Clara, USA) as previously described (Rick et al. 2013; Jayakumar et al. 2014a) , and normalized to the intensity of 4 0 ,6-diamidino-2-phenylindole (DAPI).
Statistical analysis
All experiments were performed and repeated seven to eleven times using cells derived from different batches of astrocyte and neuronal cultures. Five to six individual culture plates were used in each experimental group. Data from all experiments were subjected to analysis of variance followed by Tukey's post hoc comparisons. To analyze two independent variables, a two-way analysis of variance was performed. A value of p < 0.05 was considered significant. Error bars, mean AE SE. All cell culture procedures followed guidelines established by the National Institute of Health Guide for the Care and Use of Laboratory Animals and were approved by our Institutional Animal Care and Use Committee (IACUC).
Results
Cultured cortical neurons display a progressive increase in TDP-43 phosphorylation following single or multiple episodes of trauma Cultured neurons were traumatized, and levels of phosphorylated TDP-43 (p-TDP-43) and non-phosphorylated TDP-43 (np-TDP-43) were determined at different time points after trauma by WB. Trauma (3 atm's) to neurons resulted in a time-dependent increase (1-3-fold greater than sham controls, over 1-5 days) in p-TDP-43 levels in the cytosol ( Fig. 1a and b) , whereas no change in nuclear p-TDP-43 levels were detected 1-5 days post-trauma ( Fig. 1a and c) .
While p-TDP-43 levels were increased in the cytosol of neurons, a similar degree of trauma (3 atms) had no effect on neuronal levels of non-phosphorylated TDP-43 (np-TDP-43) at all time-points examined (1-5 days post-trauma). These findings suggest that trauma enhances the neuronal accumulation of phosphorylated TDP-43 that may ultimately impact on neuronal integrity following traumatic brain injury.
Since multiple episodes of trauma is a characteristic feature of CTE, levels of p-TDP-43 were determined in cultured neurons following exposure to three atm's of trauma at days 0 and 3 (two traumatic impacts each). On day 5 (i.e., 48 h after the second episode of the trauma), levels of p-TDP-43 were determined. Cytosolic p-TDP-43 levels were increased 7.1-fold over sham controls in traumatized neurons with two traumatic impacts ( Fig. 2a and b ), while only a threefold increase was noted 5 days after a single episode of trauma to neurons ( Fig. 1a and b) . Additionally, a 9.8-fold increase in cytosolic p-TDP-43 level was identified following three traumatic impacts (traumatized on days 0, 3, and 5 as compared to sham controls), and levels of p-TDP-43 were determined on day 7 (i.e., 48 h after the third episode of the trauma) ( Fig. 2a and b) .
We found a severalfold increase in p-tau in neurons after multiple impacts of trauma as compared to a single impact of trauma ( Fig. 2c and d) . Noteworthy, the increase in TDP-43 phosphorylation occurred earlier than the phosphorylation of p-tau. Nuclear p-TDP-43 levels were unchanged at all-time points examined after single or multiple episodes of trauma. TDP-43 phosphorylation in two controls collected from the same day as two and three impacts were analyzed. No significant change in TDP-43 phosphorylation was observed in controls over 5 and 7 days ( Fig. 2e and f) . These findings suggest that our in vitro model of trauma fully recapitulates the changes in p-TDP-43 levels observed following in vivo trauma. Since both single and multiple trauma resulted in increases in p-TDP-43 levels, the subsequent mechanistic studies were performed only following a single episode of traumatic injury.
LDH level in the medium of sham control neurons was 9.9%. After a single episode of trauma, neurons displayed a 1.9 and 3.8% increase in LDH release over control at 1 and 3 days, respectively (not statistically significant different from the sham control) (Fig. 2g) . At 5 days after a single trauma, there was a slight increase in LDH release (9.0% over sham control) which was statistically significant different from control (Fig. 2g) . Similar findings were observed 5 days after trauma with two impacts (14.6% increase over control) i.e., three atm's of trauma at days 0 and 3, and then 5 days later (i.e., 48 h after the second episode of the trauma). At 7 days after trauma following three impacts (i.e., traumatized on days 0, 3, and 5, and 48 h after the third traumatic episode) neurons exhibited a significant increase in LDH release (16.7%, over control) (Fig. 2g) .
Mechanism of TDP-43 phosphorylation TDP-43 is known to be phosphorylated by casein kinase 1e (CK1e), as well as by JNK1/2 in other conditions (Kametani et al. 2009; Suzuki and Matsuoka 2013; Choksi et al. 2014) . To determine the means by which neuronal trauma results in increased p-TDP-43 levels, protein levels of CK1e and phosphorylated JNK1/2 were examined. We found a 2-fold increase in CK1e levels (Figs. 3a and b) and a 78.4% increase in phosphorylated JNK1/2 (Fig. 3d ) 5 days posttrauma to neurons. While CK1 protein levels were increased, no change in mRNA content were identified at all time points examined (1-5 days) post-trauma (data not shown). Cotreatment of traumatized neurons with the CK1e inhibitor, PF4800567 hydrochloride (10 lM), inhibited the phosphorylation of TDP-43 by 48.7% (Fig. 3e) . While an increase in JNK1/2 activation (phosphorylation) was found in traumatized neurons, the JNK inhibitor SP600125 (1 lM) (Jayakumar et al. 2006) had no effect on TDP-43 phosphorylation (Fig. 3e ). These findings suggest that an increase in CK1e level is initially involved in the trauma-induced enhancement of TDP-43 phosphorylation.
The toxicity of phosphorylated ser [403] [404] and ser 409-410 of full length TDP-43 occurs as a consequence of its ubiquitination and subseqeunt aggregation (Inukai et al. 2008) . We therefore examined whether trauma likewise causes the ubiquitination of p-TDP-43 in cultured neurons. A 3.1-4.7-fold increase in ubiquitination of p-TDP-43 in traumatized cultured neurons was identified at 1-5 days post-trauma ( Fig. 3a and b) . Traumatized neuronal cell lysates (3 days post-trauma) were immunoprecipitated with an antibody to p-TDP-43 and then subjected to gel electrophoresis, and subsequent immunoblotting with a uibiquitin antibody. A significant increase in ubiquitinated p-TDP-43 (78%, as compared to control) (Fig. 4a) was observed. Once phosphorylated, TDP-43 is known to be translocated from the cytosol to the nucleus by importin-b. Following trauma, importin-b levels were decreased in cultured neurons (28-57% over 1-5 days) (Fig. 3a and c) , consistent with the possibility that the translocation of TDP-43 from the cytosol to the nucleus may have been impaired as a consequence of the reduction in importin-b levels.
One potential mechanism by which the TDP-43 proteinopathy may occur in CTE is through the hyperphosphorylation of tau. Hyperphosphorylated tau (p-tau) is known to inhibit proteosomal degradation, a process known to interfere with the degradation of TDP-43 (van Eersel et al. 2011; Clippinger et al. 2013) , and its accumulation in the cytosol. We found a marked increase in levels of phosphorylated tau in neurons following trauma (Fig. 3a and b) , suggesting that p-tau may indeed be involved in the accumulation of p-TDP-43 in CTE.
Additionally, oxidative stress has been shown to increase the cytosolic accumulation of phosphorylated TDP-43, along with its fragmentation and aggregation in neurons (Colombrita et al. 2009; Ayala et al. 2011; Iguchi et al. 2012) . We likewise found a reduction in p-TDP-43 levels in traumatized neurons following treatment with the antioxidant N-acetylcysteine (NAC) (Fig. 3e) . Since oxidative stress is known to activate the CK1 family of proteins (Sayed et al. 2000) , it is likely that such activation may have contributed to the increased phosphorylation of TDP-43 observed following trauma.
Effect of trauma on levels of synaptic proteins in cultured neurons To establish whether neuronal integrity is altered in CTE, we measured the levels of synaptic proteins following trauma. Cultured neurons were traumatized (3 atms), and at different time points (1-5 days) after trauma, levels of PSD95 and NR1 subunit of the NMDA receptor (NMDA-r1) were measured. We found a progressive reduction in levels of PSD95 (37-65%, over 1-5 days). We also observed that trauma resulted in a reduction in NMDA receptor levels in traumatized neurons (61.4%) (Fig. 3a and c) , consistent with a loss of neuronal integrity. (e) The CK-1e inhibitor, PF4800567 hydrochloride, and NAC inhibited the phosphorylation of TDP-43 post-trauma (5 days), while the JNK inhibitor SP600125 had no effect. ANOVA, n = 8 for (a), and 11 for (d) *p < 0.05 versus sham control. †,#p < 0.05 versus trauma. §, not statistically significant different from trauma alone. C, control; T, trauma; Error bars represent mean AE SEM. CKI, CK-1e inhibitor; JNKI, JNK inhibitor; NAC, Nacetylcysteine.
Intra-and extracellular levels of TSP-1 in traumatized cultured astrocytes Following traumatic brain injury, astrocytes display alterations in gene expression, along with a deficiency in the synthesis and release of various growth factors, including TSP-1 (Michael et al. 2005) . It is well-known that a decrease in TSP-1 synthesis and release results in defective neuronal integrity in various neurological conditions (Bu ee et al. 1992; Liauw et al. 2008; Lin et al. 2003; Yu et al. 2008) . We therefore examined whether changes in synthesis and release of TSP-1 occur in cultured astrocytes following trauma, and whether such changes contribute to the neuronal dysfunction observed in CTE.
Primary cultures of rat astrocytes were exposed to trauma (3 atms), and 1, 3, 5, 10 and 15 days later, levels of intra-and extracellular TSP-1 were measured by WB. Early following trauma (1 days), there was a twofold increase in extracellular levels of TSP-1 in astrocytes. Increases in TSP-1 were also observed 3 and 5 days post-trauma (72 and 64%, respectively), as compared to controls. However, at 10 and 15 days post-trauma extracellular levels of TSP-1 declined by 58 and 62%, respectively (Fig. 4c-f) .
TSP-1 mRNA was also measured in these cultures following trauma. While there was a significant increase in TSP-1 protein level at early stages of trauma (1 days), no change in TSP-1 mRNA expression was observed at that time point (Fig. 4b) . However, a onefold increase in TSP-1 mRNA expression was observed at 3 days after trauma (Fig. 4b) . No change in TSP-1 mRNA expression was identified at 5 and 10 days posttrauma, whereas a significant decline in TSP-1 mRNA level was detected at 15 days post-trauma (Fig. 4b) .
Effect of CM from cultured astrocytes in the early stages of trauma on neuronal TDP-43 phosphorylation post-trauma As noted above, trauma to cultured neurons displayed a 3-fold increase in p-TDP-43 levels in the cytosol. CM from traumatized astrocytes at 3 days post-trauma (which contains elevated levels of TSP-1), when added to traumatized cultured neurons, reduced levels of p-TDP-43 by 70.9% (Fig. 4g) . However, the addition of CM from traumatized astrocytes (obtained at 15 days post-trauma) to traumatized neurons (3 days post-trauma) failed to diminish p-TDP-43 levels in the cytosol (Fig. 4g ). Similar findings were identified when TSP-1 levels in the CM of astrocytes were depleted by immunoprecipitation and the resulting CM then added to cultured neurons (for 3 days), as such treatment did not reduce the trauma-induced increase in p-TDP-43 (data not shown). These findings support the critical involvement of astrocytic TSP-1 in the regulation of neuronal TDP-43 phosphorylation in CTE.
Recombinant TSP-1 or CM from traumatized TSP-1-overexpressing cultured astrocytes, when added to traumatized cultured neurons, diminishes the increase in neuronal p-TDP-43 observed following trauma To examine whether the effect of CM from traumatized astrocytes (in the early stages following trauma) on the decline in levels of neuronal TDP-43 phosphorylation might be because of an increase in astrocytic levels of TSP-1, cultured cortical neurons where exposed to recombinant TSP-1 (rTSP-1; 100 ng/mL) for 24 h, and levels of p-TDP-43 were measured by WB. Traumatized neurons displayed a 1.2-fold increase in p-TDP-43 in the cytosol, and such phosphorylation was completely inhibited by co-treatment of neurons with 100 ng/mL rTSP-1 (Fig. 5a) .
To determine whether CM from traumatized astrocytes, in which TSP-1 was over-expressed, when added to traumatized cultured neurons, diminished or prevented the increase in trauma-induced p-TDP-43 levels, TSP-1 was over-expressed (with 100 ng/mL TSP-1 cDNA) in cultured astrocytes as described previously (Jayakumar et al. 2014a) . CM from TSP-1 over-expressing astrocytes that were traumatized (15 days earlier) showed a significant increase in extracellular levels of TSP-1 (1.2-1.5-fold more than the effect of CM from traumatized astrocytes that were exposed to an "empty" vector, or with the transfection reagent alone) (data not shown). Exposure of traumatized neurons (24 h) to CM from traumatized astrocytes (15 days post-trauma, which contains very low levels of TSP-1, as compared to controls) had no effect on the trauma-induced increase in p-TDP-43. However, CM from TSP-1 over-expressing astrocytes that were traumatized (15 days earlier), when added to traumatized neurons (for 24 h), resulted in the absence of a traumainduced increase in TDP-43 phosphorylation in these cells (Fig. 5a) .
Metformin, an AMP kinase activator, is known to enhance the synthesis and release of TSP-1 (Tan et al. 2009; Ampuero et al. 2012; Jayakumar et al. 2014a) . We recently reported that exposure of astrocyte cultures to metformin (10 lM, 3 days) caused a 1-1.5 fold increase in intra-and extracellular levels of TSP-1 (Jayakumar et al. 2014a) . We therefore examined whether CM from metformin-treated astrocytes prevents or inhibits the trauma-induced increase in TDP-43 in neurons. We found that CM from metformin-treated astrocytes, when added to traumatized neurons (3 days), reduced the rise in the trauma-induced p-TDP-43 levels (by 60-70%) (Fig. 5b) . However, when metformin-treated astrocytic CM was immunoprecipitated with an antibody to TSP-1 (Fig 5c) , and that CM then added to traumatized neurons (for 3 days), such treatment did not prevent the trauma-induced rise in p-TDP-43 levels (Fig. 5b) . Successful immunodepletion of TSP-1 from the astrocyte conditioned media is shown in Fig. 5(c) . The direct exposure of traumatized neurons to metformin had no effect on the trauma-induced rise in p-TDP-43 levels (data not shown). These findings strongly suggest that the effect of the metformin-treated astrocytic CM on the reduction in TDP-43 phosphorylation following trauma is mediated as a consequence of enhanced astrocytic synthesis and release of TSP-1.
It is noteworthy that at 7 days after three impacts of trauma (i.e., traumatized on days 0, 3, and 5, and 48 h after the third episode of the trauma) neurons exhibited a significant increase in LDH release, while co-treatment of traumatized neurons with CM from metformin-treated astrocytes or rTSP-1 diminished the increase in LDH release post-trauma (61.6 and 65.2%, respectively) (Fig. 5d) , strongly suggesting that the defect in neuronal integrity following trauma can be attenuated by enhanced astrocytic synthesis and release of TSP-1.
Treatment of traumatized neurons with rTSP-1 reduces neuronal CK1e protein levels after trauma To examine potential mechanisms by which TSP-1 exerts salutary effects on traumatized neurons, we examined the effects of TSP-1 on CK1e (a kinase known to cause the phosphorylation and accumulation of TDP-43 in the cytosol). Cultured neurons were treated with rTSP-1 (100 ng/mL, 10-15 min post-trauma), and levels of neuronal CK1e were determined 5 days later by WB. rTSP-1 completely abolished the increase in CK1e protein expression in neurons post-trauma (Fig. 6a) . Additionally, exposure of traumatized neurons to CM from traumatized astrocytes in the early stages of trauma (3 days post-trauma, which contains elevated levels of TSP-1) diminished the increase in CK1e protein expression in neurons post-trauma (Fig. 6a) .
Role of importin-b
Once phosphorylated, TDP-43 is then translocated from the cytosol to the nucleus by importin b. Following trauma (5 days) importin-b levels were decreased (Fig. 6b) , and such reduction was completely abolished by rTSP-1, or by exposure of traumatized neurons to CM from traumatized astrocytes in the early stages of trauma (3 days post-trauma, which contains elevated levels of TSP-1).
CM from astrocytes derived from the later stages of trauma do not inhibit the loss of neuronal synaptic proteins posttrauma We found a 38.4% reduction in NMDA-nr1 levels in cultured neurons 3 days post-trauma (Fig. 7a) . CM from traumatized astrocytes in the early stages of trauma (3 days post-trauma, which contains elevated levels of TSP-1) when added to traumatized neurons (3 days), diminished the NMDA-nr1 reduction that occurred post-trauma (Fig. 7a) . However, when TSP-1 levels in the CM of traumatized astrocytes (3 days, post-trauma) were depleted by immunoprecipitation, and the resulting CM then added to traumatized neurons (for 3 days), such treatment did not prevent the trauma-induced decrease in NMDA-nr1 levels (Fig. 7a) .
Similar to NMDA-nr1, we found a 55% reduction in PSD95 levels in traumatized cultured neurons (Fig. 7b) . CM from traumatized astrocytes in the early stages of trauma (3 days post-trauma, which contains elevated levels of TSP-1), when added to traumatized neurons (3 days), blocked the reduction in PSD95 levels that had occurred post-trauma (Fig. 7b) . Further, when TSP-1 levels in the CM of traumatized astrocytes (3 days, post-trauma) were depleted by immunoprecipitation, and the resulting CM added to traumatized neurons (for 3 days), this procedure did not prevent the trauma-induced decrease in PSD95 levels (Fig. 7b) .
When CM from cultured astrocytes 15 days post-trauma, in which TSP-1 was over-expressed by the addition of TSP-1 cDNA, and that CM then added to traumatized neurons (for 3 days), such treatment completely blocked the reduction in PSD95 levels that occurred post-trauma (Fig. 7c) . Additionally, we found that treatment of traumatized neurons with recombinant TSP-1 (rTSP-1), or with the CK1 inhibitor, PF4800567 hydrochloride (10 lM), reduced the traumainduced reduction in PSD95 by 72.6 and 54.7%, respectively (Fig. 7c) . We also found that treatment of neurons with the antioxidant NAC significantly diminished the reduction in PSD95 levels that occurred post-trauma (Fig. 7d) , suggesting that the reduction in TDP-43 phosphorylation by NAC is indeed functionally relevant.
In addition to western blots analysis, we also examined changes in PSD95 puncta in traumatized neurons by immunofluorescence. Neuronal cultures were traumatized, and levels of PSD95 puncta were analyzed 3 days later. Trauma caused a significant loss of PSD95 puncta (58.9%) (Figs. 8a-b) . We then examined whether astrocytic TSP-1 plays a role in the loss of PSD95 post-trauma. Accordingly, cultured astrocytes were traumatized and the CM from traumatized astrocytes were collected 24 h later (which contains high levels of TSP-1), and subsequently added to traumatized neurons. Three days post-treatment of traumatized neurons with astrocytic CM, levels of PSD95 were measured by immunofluorescence. This approach significantly reversed the reduction in PSD95 puncta post-trauma (by 72.6%) (Fig. 8c) . Further, exposure of traumatized neurons to rTSP-1 or to CM from metformin-treated astrocytes reversed the reduction in PSD95 (76.1 and 71.7%, respectively) (Figs. 8d-e) .
Since importin-b levels are reduced in traumatized neurons (Fig. 3a) , and such reduction has been shown to cause the neuronal TDP-43 proteinopathy in other conditions (Sato et al. 2009; Nishimura et al. 2010; Shindo et al. 2013) , we examined whether such events contributes to the defective neuronal integrity post-trauma. We therefore silenced importin-b in cultured neurons by siRNA, and examined whether such inhibition contributes to the reduction in PSD95. Exposure of neurons to siRNA specific to importin-b (20 ng/mL for 48 h), significantly reduced both mRNA and protein levels (by 78.6 and 59.4%, respectively). This reduction in importin-b levels resulted in a significant loss in PSD95 puncta (by 60.23%) (Fig. 8i) . Silencing importin-b also increased the accumulation of cytosolic p-TDP-43 (Fig. 8l) . These findings suggest that an increase in cytosolic p-TDP-43 levels, by a reduction in importin-b levels, may have contributed to the defective neuronal integrity associated with trauma.
Discussion
Our findings demonstrate that cultured neurons subjected to single or multiple episodes of trauma, exhibit hyperphosphorylation of TDP-43, along with its ubiquitination (the TDP-43 proteinopathy). The means by which phosphorylated TDP-43 contributes to neuronal injury is poorly understood. Studies have shown that transgenic mice that over-express full-length TDP-43 display aggregation of p-TDP-43 that ultimately results in neurotoxicity (Inukai et al. 2008) . Additionally, p-TDP-43 was shown to exhibit a longer half-life than nonphosphorylated TDP-43, resulting in its accumulation and potential neurotoxicity (Zhang et al. 2009 ). We indeed found increased neuronal p-TDP-43 levels in the cytosol after single or multiple episodes of trauma in vitro, consistent with the presence of impaired neuronal integrity in CTE. While the TDP-43 proteinopathy has been demonstrated in single or multiple episodes of head trauma in humans (Miller 1966; Omalu et al. 2011 ), Johnson et al. 2011 reported that total, but not phosphorylated TDP-43 levels, are increased in Fig. 6 (a) Exposure of cultured traumatized neurons (5 days) to conditioned media (CM) from traumatized astrocytes (ACM) (3 days), which contains elevated levels of thrombospondin-1 (TSP-1), or to 100 ng/mL rTSP-1 prevented the trauma-induced increase in CK1e (which is known to phosphorylate transactivating DNA-binding protein-43). (b) Exposure of cultured traumatized neurons (5 days) to CM from traumatized astrocytes (3 days) or to rTSP-1, reversed the traumainduced reduction in importin-b levels. ANOVA, n = 9. *p < 0.05 versus sham control. †p < 0.05 versus trauma. C, sham control; T, trauma. Error bars represent mean AE SEM. C, sham control; T, trauma. postmortem brain tissue from patients who had experienced with a single episode of traumatic brain injury. The reason for the absence of p-TDP-43 in their study may be because of a difficulty in measuring phosphoproteins levels in postmortem human brain specimens (Li et al. 2003) .
Another means by which cytosolic p-TDP-43 accumulation and its subsequent toxicity occurs in neurons is through alterations in its translocation (Guo et al. 2010) . Once phosphorylated in the cytosol, p-TDP-43 is then transported to the nucleus by a carrier protein (importin-b) (Sato et al. 2009; Nishimura et al. 2010; Shindo et al. 2013) , where it is normally localized (Zhang et al. 2007; Barmada et al. 2010; Buratti et al. 2010 ).
The precise mechanism by which alterations in importin-b levels result in increased levels of cytosolic p-TDP-43 following traumatic injury has not been elucidated. In an in vivo model of chronic cerebral ischemia in rats, a reduction in neuronal importin-b levels, along with a concomitant increase in p-TDP-43, were observed (Shindo et al. 2013) . These investigators suggested that a reduction in levels of importin a and b contributed to the accumulation of p-TDP-43 in the cytosol. We similarly found a decrease in importinb levels in traumatized cultured neurons, while silencing importin-b expression significantly increased the accumulation of p-TDP-43 in the cytosol, suggesting that decreased importin-b levels may have been responsible for the failure Fig. 7 (a and b) NR1 subunits of the NMDA receptor (NMDA-nr1) and PSD95 levels are decreased in cultured neurons post-trauma. However, exposure of traumatized neurons to conditioned media (CM) from traumatized astrocytes (i.e., astrocyte conditioned medium; ACM) which contains elevated levels of thrombospondin-1 (TSP-1), diminished the trauma-induced reduction in the NMDA-nr1. However, when TSP-1 levels in the CM of traumatized astrocytes (3 days, post-trauma) were depleted by immunoprecipitation (IP-ACM), and the resulting CM then added to traumatized neurons (for 3 days), this procedure did not prevent the trauma-induced decrease in NMDA-nr1 levels. (c) When CM from cultured astrocytes 15 days post-trauma, in which TSP-1 was over-expressed by the addition of TSP-1 cDNA, and that CM then added to traumatized neurons (for 3 days), such treatment completely blocked the reduction in PSD95 levels that occurred post-trauma. Treatment of traumatized neurons with recombinant TSP-1 (rTSP-1), or with the CK1 inhibitor, PF4800567 hydrochloride, reduced the traumainduced reduction in PSD95. (d) Treatment of neurons with the antioxidant NAC significantly diminished the reduction in PSD95 levels that occurred post-trauma. ANOVA, n = 8 for (a) and (b), and 7 and 10 for (c) and (d), respectively. *p < 0.05 versus sham control. †p < 0.05 versus trauma. Error bars represent mean AE SEM. C, sham control; T, trauma.
of TDP-43 transport into nuclei and its subsequent accumulation in the cytosol. While the precise mechanisms by which the phosphorylation of TDP-43 occurs in CTE is not fully understood, it is likely that CK1e, ERK1/2 and JNK1/2 are involved, as these kinases have been reported to phosphorylate TDP-43 in other conditions (Kametani et al. 2009; Ayala et al. 2011; Suzuki and Matsuoka 2013; Choksi et al. 2014) . Additionally, oxidative stress has been shown to increase the cytosolic accumulation of phosphorylated TDP-43, along with its fragmentation and aggregation in neurons (Colombrita et al. 2009; Ayala et al. 2011; Iguchi et al. 2012) . We also found increased CK1e and JNK1/2 phosphorylation (activation) in traumatized neuronal cultures, while the CK1e inhibitor, PF4800567 hydrochloride, but not the JNK1/2 inhibitor, SP600125, reduced the level of p-TDP-43. Additionally, a reduction in p-TDP-43 levels was observed in traumatized neurons following treatment with the antioxidant NAC. Collectively, these findings suggest that the activation of CK1e (by oxidative stress) may have contributed to the increased phosphorylation of TDP-43 that occurs following trauma.
Trauma to cultured neurons in vitro, also resulted in an increase in phosphorylated and ubiquitinated forms of TDP-43, a characteristic feature of CTE. Since phosphorylation of ser [403] [404] and ser [409] [410] of full length TDP-43 was previously shown in other conditions to initiate its toxicity primarily by forming ubiquitinated proteins leading to their aggregation and neurotoxicity (Inukai et al. 2008) , it is likely that increased ubiquitination of p-TDP-43 following trauma initiates a process that ultimately results in the neurodegeneration associated with CTE. One potential mechanism by which the TDP-43 proteinopathy is triggered in CTE is through the hyperphosphorylation of tau (p-Tau). p-Tau is known to inhibit proteosomal degradation, a process known to interfere with the degradation of TDP-43 (van Eersel et al. 2011; Clippinger et al. 2013) , thus enhancing its cytosolic accumulation. We indeed found a marked increase in levels of p-tau in neurons following a single or multiple episodes of in vitro trauma. However, this incerase was not involved in the TDP-43 proteinopathy, as we observed an increase in TDP-43 prior to the phosphorylation of tau. Additionally, when traumatized neurons were co-treated with the proteasome inhibitor MG132 (5 lM) for 24 h, such treatment had no effect on p-TDP-43 levels, suggesting that p-tau may not be involved in the neuronal accumulation of p-TDP-43 or in the development of CTE. Alternatively, a potential involvement of p-tau as a contributng factor in the pathogenesis of CTE, however, cannot be completely excluded.
There is currently no information on the involvement of astrocytes in the pathogenesis of CTE. Astrocytic dysfunction has been observed following trauma (Burda et al. 2016 and references therein). While astrocytes are critical for the maintenance of neuronal integrity (see Introduction), the precise role of dysfunctional astrocytes in CTE is not clear. Based on the findings of the present study, one mechanism by which defective astrocytes may negatively impact on neuronal integrity is through a reduction in their levels of TSP-1.
TSP-1 is a member of the thrombospondin family of proteins that in humans is encoded by the THBS1 gene (Jaffe et al. 1990; Wolf et al. 1990 ). TSP-1 can bind to fibrinogen, fibronectin, laminin, type V collagen and integrins alpha-V/beta-1, and thereby elicit signaling events (Li et al. 2002; Eroglu et al. 2009 ) leading to the transcriptional up-regulation of genes coding for several synaptic proteins (e.g., synaptophysin, synaptotagmin, PSD95) (Yu et al. 2008; Huang et al. 2013; Jayakumar et al. 2014a) .
Astrocytes are known to synthesize and secrete TSP-1 (Christopherson et al. 2005; Tran and Neary 2006; Jayakumar et al. 2014a) , and a reduction in TSP-1 expression by siRNA silencing was shown to decrease neuronal synaptophysin protein expression (Yu et al. 2008) . Such reduction in TSP-1 and synaptophysin protein levels has also been associated with behavioral abnormalities in experimental models of stroke (Lin et al. 2003; Liauw et al. 2008 ), Alzheimer's disease (Bu ee et al. 1992), Down's syndrome (Garcia et al. 2010) , and chronic hepatic encephalopathy (Jayakumar et al. 2014a) .
We also observed a significant increase in TSP-1 synthesis and release when cultured astrocytes were exposed to trauma. Additionally, exposure of traumatized neurons to CM from traumatized astrocytes at early stages led to a decrease in p-TDP-43 levels, as well as to a reversal of the trauma-induced reduction in PSD95 and NMDA-nr1 levels. Additionally, exposure of traumatized neurons to recombinant TSP-1 diminished the phosphorylation of TPD-43, as well as reversed the trauma-induced reduction in PSD95 and NMDA-nr1 levels. In aggregate, these findings suggest that during the early phase of trauma astrocytes exert neuroprotective effects, likely by enhancing the synthesis and release of TSP-1; however, at later stages of trauma astrocytes failed to synthesize and release TSP-1. Such failure likely contributed to the neuronal TDP-43 proteinopathy and to the reduction in levels of neuronal synaptic proteins following trauma. While the reason for the decrease in the synthesis and release of TSP-1 in traumatized astrocytes at late stages of trauma is unclear, it is possible that traumatic injury may have increased c-Myc expression, an event well-known to inhibit TSP-1 synthesis and release in other conditions (Jayakumar et al. 2014a , and references therein).
In summary, our findings suggest that trauma to cultured neurons leads to the phosphorylation, ubiquitination and aggregation of TDP-43, as well as to a decrease in the level of neuronal proteins (PSD95 and the NMDA receptor). CM from astrocytes in the early stages following trauma (when TSP-1 synthesis and release are increased), when added to traumatized cultured neurons, mitigated the enhanced levels of p-TDP-43, as well as prevented the reduction of PSD95 and NMDA-nr1 levels. However, at later stages of trauma (15 days post-trauma), astrocytes failed to exert a neuroprotective effect, in part, likely because of impaired astrocytic synthesis and release of TSP-1 (Fig. 9) . Targeting the neuronal p-TDP-43 proteinopathy by enhancing the astrocytic synthesis and release of TSP-1 may provide a novel therapeutic approach for the treatment of chronic traumatic encephalopathy.
